Home/Pipeline/CLB101™ (Anaerostipes caccae)

CLB101™ (Anaerostipes caccae)

Gut Health (Support of barrier function, immunity, microbiome balance)

Pre-clinicalActive Development

Key Facts

Indication
Gut Health (Support of barrier function, immunity, microbiome balance)
Phase
Pre-clinical
Status
Active Development
Company

About ClostraBio

ClostraBio is focused on restoring intestinal barrier-protective function and innate immunity to maintain gut health and treat diseases of the gut and food allergy. The company leverages a well-rounded team of scientists and entrepreneurs with expertise in microbiology and bioengineering to develop both a dietary supplement and a versatile delivery platform. Their core technology aims to transform intestinal health through targeted metabolite delivery, addressing significant unmet needs in the IBD and food allergy markets.

View full company profile